mple
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark one)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
March 31, 2017
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 1-9576
OWENS-ILLINOIS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
22-2781933 |
(State or other jurisdiction of |
|
(IRS Employer |
incorporation or organization) |
|
Identification No.) |
One Michael Owens Way, Perrysburg, Ohio |
|
43551 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (567) 336-5000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒ |
Accelerated filer ☐ |
Non-accelerated filer ☐ (Do not check if a smaller reporting company)
|
|
|
|
||
Smaller reporting company ☐ |
Emerging growth company ☐ |
||
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares of common stock, par value $.01, of Owens-Illinois, Inc. outstanding as of March 31, 2017 was 162,698,113.
Part I — FINANCIAL INFORMATION
The Condensed Consolidated Financial Statements of Owens-Illinois, Inc. (the “Company”) presented herein are unaudited but, in the opinion of management, reflect all adjustments necessary to present fairly such information for the periods and at the dates indicated. All adjustments are of a normal recurring nature. Because the following unaudited condensed consolidated financial statements have been prepared in accordance with Article 10 of Regulation S-X, they do not contain all information and footnotes normally contained in annual consolidated financial statements; accordingly, they should be read in conjunction with the Consolidated Financial Statements and notes thereto appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.
1
OWENS-ILLINOIS, INC.
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS
(Dollars in millions, except per share amounts)
|
|
Three months ended |
|
|
||||
|
|
March 31, |
|
|
||||
|
|
2017 |
|
2016 |
|
|
||
Net sales |
|
$ |
1,615 |
|
$ |
1,588 |
|
|
Cost of goods sold |
|
|
(1,300) |
|
|
(1,269) |
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
315 |
|
|
319 |
|
|
|
|
|
|
|
|
|
|
|
Selling and administrative expense |
|
|
(119) |
|
|
(129) |
|
|
Research, development and engineering expense |
|
|
(15) |
|
|
(15) |
|
|
Interest expense, net |
|
|
(78) |
|
|
(66) |
|
|
Equity earnings |
|
|
15 |
|
|
14 |
|
|
Other expense, net |
|
|
(45) |
|
|
(22) |
|
|
|
|
|
|
|
|
|
|
|
Earnings from continuing operations before income taxes |
|
|
73 |
|
|
101 |
|
|
Provision for income taxes |
|
|
(20) |
|
|
(27) |
|
|
|
|
|
|
|
|
|
|
|
Earnings from continuing operations |
|
|
53 |
|
|
74 |
|
|
Loss from discontinued operations |
|
|
|
|
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
Net earnings |
|
|
53 |
|
|
73 |
|
|
Net earnings attributable to noncontrolling interests |
|
|
(4) |
|
|
(6) |
|
|
Net earnings attributable to the Company |
|
$ |
49 |
|
$ |
67 |
|
|
|
|
|
|
|
|
|
|
|
Amounts attributable to the Company: |
|
|
|
|
|
|
|
|
Earnings from continuing operations |
|
$ |
49 |
|
$ |
68 |
|
|
Loss from discontinued operations |
|
|
|
|
|
(1) |
|
|
Net earnings |
|
$ |
49 |
|
$ |
67 |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
Earnings from continuing operations |
|
$ |
0.30 |
|
$ |
0.42 |
|
|
Loss from discontinued operations |
|
|
|
|
|
(0.01) |
|
|
Net earnings |
|
$ |
0.30 |
|
$ |
0.41 |
|
|
|
|
|
|
|
|
|
|
|
Weighted averages shares outstanding (thousands) |
|
|
162,388 |
|
|
161,204 |
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
|
|
|
|
|
|
|
Earnings from continuing operations |
|
$ |
0.30 |
|
$ |
0.42 |
|
|
Loss from discontinued operations |
|
|
|
|
|
(0.01) |
|
|
Net earnings |
|
$ |
0.30 |
|
$ |
0.41 |
|
|
|
|
|
|
|
|
|
|
|
Weighted average diluted shares outstanding (thousands) |
|
|
163,840 |
|
|
161,793 |
|
|
See accompanying notes.
2
OWENS-ILLINOIS, INC.
CONDENSED CONSOLIDATED COMPREHENSIVE INCOME
(Dollars in millions)
|
|
Three months ended |
|
|
||||
|
|
March 31, |
|
|
||||
|
|
2017 |
|
2016 |
|
|
||
Net earnings |
|
$ |
53 |
|
$ |
73 |
|
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
189 |
|
|
94 |
|
|
Pension and other postretirement benefit adjustments, net of tax |
|
|
11 |
|
|
(42) |
|
|
Change in fair value of derivative instruments, net of tax |
|
|
(6) |
|
|
(2) |
|
|
Other comprehensive income |
|
|
194 |
|
|
50 |
|
|
Total comprehensive income |
|
|
247 |
|
|
123 |
|
|
Comprehensive (income) attributable to noncontrolling interests |
|
|
(7) |
|
|
(9) |
|
|
Comprehensive income attributable to the Company |
|
$ |
240 |
|
$ |
114 |
|
|
See accompanying notes.
3
OWENS-ILLINOIS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in millions)
|
|
March 31, |
|
December 31, |
|
March 31, |
|
|||
|
|
2017 |
|
2016 |
|
2016 |
|
|||
Assets |
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
312 |
|
$ |
492 |
|
$ |
239 |
|
Trade receivables, net of allowance of $36 million, $32 million, and $31 million at March 31, 2017, December 31, 2016 and March 31, 2016 |
|
|
844 |
|
|
580 |
|
|
771 |
|
Inventories |
|
|
1,051 |
|
|
983 |
|
|
1,107 |
|
Prepaid expenses and other current assets |
|
|
212 |
|
|
199 |
|
|
359 |
|
Total current assets |
|
|
2,419 |
|
|
2,254 |
|
|
2,476 |
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
2,926 |
|
|
2,880 |
|
|
2,996 |
|
Goodwill |
|
|
2,524 |
|
|
2,462 |
|
|
2,532 |
|
Intangibles, net |
|
|
485 |
|
|
464 |
|
|
587 |
|
Other assets |
|
|
1,105 |
|
|
1,075 |
|
|
1,097 |
|
Total assets |
|
$ |
9,459 |
|
$ |
9,135 |
|
$ |
9,688 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Share Owners' Equity |
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
|
Short-term loans and long-term debt due within one year |
|
$ |
196 |
|
$ |
195 |
|
$ |
239 |
|
Current portion of asbestos-related liabilities |
|
|
115 |
|
|
115 |
|
|
130 |
|
Accounts payable |
|
|
1,017 |
|
|
1,135 |
|
|
1,050 |
|
Other liabilities |
|
|
531 |
|
|
615 |
|
|
467 |
|
Total current liabilities |
|
|
1,859 |
|
|
2,060 |
|
|
1,886 |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
5,431 |
|
|
5,133 |
|
|
5,662 |
|
Asbestos-related liabilities |
|
|
565 |
|
|
577 |
|
|
676 |
|
Other long-term liabilities |
|
|
988 |
|
|
1,002 |
|
|
1,048 |
|
Share owners' equity |
|
|
616 |
|
|
363 |
|
|
416 |
|
Total liabilities and share owners' equity |
|
$ |
9,459 |
|
$ |
9,135 |
|
$ |
9,688 |
|
See accompanying notes.
4
OWENS-ILLINOIS, INC.
CONDENSED CONSOLIDATED CASH FLOWS
(Dollars in millions)
|
|
Three months ended March 31, |
|
|
||||
|
|
2017 |
|
2016 |
|
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net earnings |
|
$ |
53 |
|
$ |
73 |
|
|
Loss from discontinued operations |
|
|
— |
|
|
1 |
|
|
Non-cash charges |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
127 |
|
|
125 |
|
|
Pension expense |
|
|
7 |
|
|
6 |
|
|
Restructuring, asset impairment and related charges |
|
|
38 |
|
|
19 |
|
|
Cash payments |
|
|
|
|
|
|
|
|
Pension contributions |
|
|
(14) |
|
|
(4) |
|
|
Asbestos-related payments |
|
|
(12) |
|
|
(11) |
|
|
Cash paid for restructuring activities |
|
|
(8) |
|
|
(13) |
|
|
Change in components of working capital |
|
|
(542) |
|
|
(488) |
|
|
Other, net (a) |
|
|
14 |
|
|
(9) |
|
|
Cash utilized in continuing operating activities |
|
|
(337) |
|
|
(301) |
|
|
Cash utilized in discontinued operating activities |
|
|
|
|
|
(1) |
|
|
Total cash utilized in operating activities |
|
|
(337) |
|
|
(302) |
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Additions to property, plant and equipment |
|
|
(98) |
|
|
(117) |
|
|
Acquisitions, net of cash acquired |
|
|
(17) |
|
|
(22) |
|
|
Other, net |
|
|
1 |
|
|
6 |
|
|
Cash utilized in investing activities |
|
|
(114) |
|
|
(133) |
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Changes in borrowings, net |
|
|
273 |
|
|
274 |
|
|
Issuance of common stock and other |
|
|
3 |
|
|
5 |
|
|
Payment of finance fees |
|
|
(19) |
|
|
(3) |
|
|
Cash provided by financing activities |
|
|
257 |
|
|
276 |
|
|
Effect of exchange rate fluctuations on cash |
|
|
14 |
|
|
(1) |
|
|
Decrease in cash |
|
|
(180) |
|
|
(160) |
|
|
Cash at beginning of period |
|
|
492 |
|
|
399 |
|
|
Cash at end of period |
|
$ |
312 |
|
$ |
239 |
|
|
(a) |
Other, net includes other non-cash charges plus other changes in non-current assets and liabilities. |
See accompanying notes.
5
OWENS-ILLINOIS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Tabular data dollars in millions, except per share amounts
1. Segment Information
The Company has four reportable segments based on its geographic locations: Europe, North America, Latin America and Asia Pacific. These four segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, and certain equity investments. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.
The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations as well as certain retained corporate costs. The Company’s management uses segment operating profit, in combination with selected cash flow information, to evaluate performance and to allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided.
Intercompany sales in Latin America totaled $33 million and $50 million for the three months ended March 31, 2017 and 2016, respectively.
Financial information for the three months ended March 31, 2017 and 2016 regarding the Company’s reportable segments is as follows:
|
|
Three months ended March 31, |
|
||||
|
|
2017 |
|
2016 |
|
||
Net sales: |
|
|
|
|
|
|
|
Europe |
|
$ |
554 |
|
$ |
563 |
|
North America |
|
|
528 |
|
|
532 |
|
Latin America |
|
|
341 |
|
|
312 |
|
Asia Pacific |
|
|
173 |
|
|
159 |
|
Reportable segment totals |
|
|
1,596 |
|
|
1,566 |
|
Other |
|
|
19 |
|
|
22 |
|
Net sales |
|
$ |
1,615 |
|
$ |
1,588 |
|
|
|
Three months ended March 31, |
|
||||
|
|
2017 |
|
2016 |
|
||
Segment operating profit: |
|
|
|
|
|
|
|
Europe |
|
$ |
59 |
|
$ |
55 |
|
North America |
|
|
85 |
|
|
76 |
|
Latin America |
|
|
54 |
|
|
63 |
|
Asia Pacific |
|
|
20 |
|
|
17 |
|
Reportable segment totals |
|
|
218 |
|
|
211 |
|
Items excluded from segment operating profit: |
|
|
|
|
|
|
|
Retained corporate costs and other |
|
|
(28) |
|
|
(32) |
|
Restructuring, asset impairment and other |
|
|
(39) |
|
|
(12) |
|
Interest expense, net |
|
|
(78) |
|
|
(66) |
|
Earnings from continuing operations before income taxes |
|
$ |
73 |
|
$ |
101 |
|
6
Financial information regarding the Company’s total assets is as follows:
|
|
|
March 31, |
|
December 31, |
|
March 31, |
|||
|
|
|
2017 |
|
2016 |
|
2016 |
|||
Total assets: |
|
|
|
|
|
|
|
|
|
|
Europe |
|
$ |
2,858 |
|
$ |
2,792 |
|
$ |
3,047 |
|
North America |
|
|
2,742 |
|
|
2,522 |
|
|
2,550 |
|
Latin America |
|
|
2,691 |
|
|
2,537 |
|
|
2,855 |
|
Asia Pacific |
|
|
998 |
|
|
926 |
|
|
933 |
|
|
|
|
|
|
|
|
|
|
|
|
Reportable segment totals |
|
|
9,289 |
|
|
8,777 |
|
|
9,385 |
|
Other |
|
|
170 |
|
|
358 |
|
|
303 |
|
Consolidated totals |
|
$ |
9,459 |
|
$ |
9,135 |
|
$ |
9,688 |
|
2. Inventories
Major classes of inventory at March 31, 2017, December 31, 2016 and March 31, 2016 are as follows:
|
|
March 31, |
|
December 31, |
|
March 31, |
|
|
|||
|
|
2017 |
|
2016 |
|
2016 |
|
|
|||
Finished goods |
|
$ |
889 |
|
$ |
827 |
|
$ |
954 |
|
|
Raw materials |
|
|
124 |
|
|
118 |
|
|
116 |
|
|
Operating supplies |
|
|
38 |
|
|
38 |
|
|
37 |
|
|
|
|
$ |
1,051 |
|
$ |
983 |
|
$ |
1,107 |
|
|
3. Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets at March 31, 2017, December 31, 2016 and March 31, 2016 are as follows:
|
|
March 31, |
|
December 31, |
|
March 31, |
|||
|
|
2017 |
|
2016 |
|
2016 |
|||
Prepaid expenses |
|
$ |
64 |
|
$ |
50 |
|
$ |
52 |
Value added taxes |
|
|
49 |
|
|
46 |
|
|
192 |
Other |
|
|
99 |
|
|
103 |
|
|
115 |
|
|
$ |
212 |
|
$ |
199 |
|
$ |
359 |
4. Derivative Instruments
The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign exchange option and forward contracts. The Company uses an income approach to value these contracts. Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models. These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. The Company also evaluates counterparty risk in determining fair values.
Commodity Forward Contracts Designated as Cash Flow Hedges
In several regions, the Company enters into commodity forward contracts related to forecasted natural gas requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows. In North America, the majority of its customer contracts contain provisions that pass the price of natural gas to its customers. In certain of these contracts, the customer has the option of fixing the natural gas price component for a specified period of time. To limit the effects of fluctuations in cash flows resulting from these customer contracts, the Company enters into commodity forward contracts related to forecasted natural gas requirements. In Asia Pacific, the Company implemented a hedging program in the first quarter of 2016, which included
7
the execution of commodity forward contracts for certain contracted natural gas requirements. At March 31, 2017 and 2016, the Company had entered into commodity forward contracts covering approximately 11,200,000 MM BTUs and 12,600,000 MM BTUs, respectively.
The Company accounts for the above forward contracts as cash flow hedges at March 31, 2017 and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified into earnings in the same period or periods during which the underlying hedged item affects earnings. An unrecognized gain of $1 million at March 31, 2017, an unrecognized gain of $6 million at December 31, 2016 and an unrecognized loss of $4 million at March 31, 2016 related to the commodity forward contracts was included in Accumulated OCI, and will be reclassified into earnings in the period when the commodity forward contracts expire. Any material portion of the change in the fair value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current earnings. The ineffectiveness related to these natural gas hedges for the three months ended March 31, 2017 and 2016 was not material.
The effect of the commodity forward contracts on the results of operations for the three months ended March 31, 2017 and 2016 is as follows:
|
|
Amount of Gain Reclassified from |
|
||||||||
Amount of Gain (Loss) Recognized in OCI on |
|
Accumulated OCI into Income |
|
||||||||
Commodity Forward Contracts |
|
(reported in cost of goods sold) |
|
||||||||
(Effective Portion) |
|
(Effective Portion) |
|
||||||||
2017 |
|
2016 |
|
2017 |
|
2016 |
|
||||
$ |
6 |
|
$ |
(4) |
|
$ |
— |
|
$ |
2 |
|
Foreign Exchange Derivative Contracts and not Designated as Hedging Instruments
The Company may enter into short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company may also use foreign exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies. The Company records these short-term foreign exchange agreements on the balance sheet at fair value and changes in the fair value are recognized in current earnings.
At March 31, 2017 and 2016, the Company had outstanding foreign exchange and option agreements denominated in various currencies covering the equivalent of approximately $340 million and $660 million, respectively, related primarily to intercompany transactions and loans.
The effect of the foreign exchange derivative contracts on the results of operations for the three months ended March 31, 2017 and 2016 is as follows:
|
|
Amount of Gain (Loss) |
|
||||
Location of Gain (Loss) |
|
Recognized in Income on |
|
||||
Recognized in Income on |
|
Foreign Exchange Contracts |
|
||||
Foreign Exchange Contracts |
|
2017 |
|
2016 |
|
||
Other expense |
|
$ |
— |
|
$ |
5 |
|
Balance Sheet Classification
The Company records the fair values of derivative financial instruments on the balance sheet as follows: (a) receivables if the instrument has a positive fair value and maturity within one year, (b) deposits, receivables, and other assets if the instrument has a positive fair value and maturity after one year, and (c) other accrued liabilities or other liabilities (current) if the instrument has a negative fair value and maturity within one year.
8
The following table shows the amount and classification (as noted above) of the Company’s derivatives at March 31, 2017, December 31, 2016 and March 31, 2016:
|
|
Fair Value |
|
|
|||||||||
|
|
Balance Sheet |
|
March 31, |
|
December 31, |
|
March 31, |
|
|
|||
|
|
Location |
|
2017 |
|
2016 |
|
2016 |
|
|
|||
Asset derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity futures contracts |
|
a |
|
$ |
2 |
|
$ |
6 |
|
$ |
— |
|
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange derivative contracts |
|
a |
|
|
5 |
|
|
9 |
|
|
15 |
|
|
Total asset derivatives |
|
|
|
$ |
7 |
|
$ |
15 |
|
$ |
15 |
|
|
Liability derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity futures contracts |
|
c |
|
$ |
1 |
|
$ |
— |
|
$ |
4 |
|
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange derivative contracts |
|
c |
|
|
2 |
|
|
5 |
|
|
2 |
|
|
Total liability derivatives |
|
|
|
$ |
3 |
|
$ |
5 |
|
$ |
6 |
|
|
5. Restructuring Accruals
Selected information related to the restructuring accruals for the three months ended March 31, 2017 and 2016 is as follows:
|
|
Other |
|
|
|
|
Restructuring |
|
|
|
|
Actions |
|
|
Balance at January 1, 2017 |
|
$ |
85 |
|
Charges |
|
|
38 |
|
Write-down of assets to net realizable value |
|
|
(9) |
|
Net cash paid, principally severance and related benefits |
|
|
(8) |
|
Other, including foreign exchange translation |
|
|
(2) |
|
Balance at March 31, 2017 |
|
$ |
104 |
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
Asia Pacific |
|
Restructuring |
|
Total |
|
|||
|
|
Restructuring |
|
Actions |
|
Restructuring |
|
|||
Balance at January 1, 2016 |
|
$ |
7 |
|
$ |
36 |
|
$ |
43 |
|
Charges |
|
|
1 |
|
|
18 |
|
|
19 |
|
Write-down of assets to net realizable value |
|
|
|
|
|
(7) |
|
|
(7) |
|
Net cash paid, principally severance and related benefits |
|
|
(1) |
|
|
(12) |
|
|
(13) |
|
Other, including foreign exchange translation |
|
|
(1) |
|
|
(1) |
|
|
(2) |
|
Balance at March 31, 2016 |
|
$ |
6 |
|
$ |
34 |
|
$ |
40 |
|
The Company’s decisions to curtail selected production capacity have resulted in write downs of certain long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell. The Company classified the significant assumptions used to determine the fair value of the impaired assets, which was not material, as Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements.
When a decision is made to take these actions, the Company manages and accounts for them separately from the on-going operations of the business. Information related to major programs (as in the case of the Asia Pacific Restructuring program above) are presented separately. Minor initiatives and discrete restructuring actions are presented on a combined basis as Other Restructuring Actions. When charges related to major programs are completed, remaining accrual balances are classified within Other Restructuring Actions.
9
Asia Pacific Restructuring
During the three months ended March 31, 2016, the Company recorded charges of $1 million. These charges primarily represented other exit costs as part of the Company’s Asia Pacific Restructuring program. The Company recorded total cumulative charges of $224 million and does not expect to execute any further actions under this program. The Company expects that the majority of the remaining cash expenditures related to the above charges will be paid out by the end of 2017.
Other Restructuring Actions
During the three months ended March 31, 2017, the Company recorded restructuring, asset impairment and other charges of $38 million. These charges primarily consist of employee costs, write-down of assets, and other exit costs in the following regions: Latin America ($23 million), Europe ($13 million) and North America ($2 million). Except for the charges recorded in Europe, the discrete restructuring charges recorded in the first quarter of 2017 are expected to approximate the total cumulative costs for those actions as no significant additional costs are expected to be incurred. Since 2016, the Company has recorded total cumulative charges of $54 million related to a plant closure in Europe and does not expect to execute any further significant actions related to this facility. The restructuring charges recorded in the first quarter of 2017 in the Latin American and European regions primarily relate to capacity curtailments. The Company plans to reallocate the products produced at these facilities to others in their respective regions. The Company expects that the majority of the remaining cash expenditures related to the above charges will be paid out by the end of 2018.
During the three months ended March 31, 2016, the Company recorded charges of $18 million. These charges primarily represented employee costs, write-down of assets, and other exit costs of $14 million for a plant closure in the first quarter of 2016 in Latin America, $3 million related to a previous plant closure in North America and $1 million related to other restructuring actions. The discrete restructuring charges recorded in the first quarter of 2016 are expected to approximate the total cumulative costs for those actions as no significant additional costs are expected to be incurred. The restructuring charges recorded in the first quarter of 2016 in the Latin American region primarily relate to a capacity curtailment. The Company reallocated the products produced at this facility to others in the region. The Company expects that the majority of the remaining cash expenditures related to the above charges will be paid out by the end of 2017.
6. Pension Benefit Plans
The components of the net periodic pension cost for the three months ended March 31, 2017 and 2016 are as follows:
|
|
U.S. |
|
Non-U.S. |
|
||||||||
|
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
||||
Service cost |
|
$ |
4 |
|
$ |
4 |
|
$ |
4 |
|
$ |
4 |
|
Interest cost |
|
|
20 |
|
|
24 |
|
|
11 |
|
|
13 |
|
Expected asset return |
|
|
(33) |
|
|
(38) |
|
|
(18) |
|
|
(21) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior service cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss |
|
|
14 |
|
|
15 |
|
|
5 |
|
|
5 |
|
Net periodic pension cost |
|
$ |
5 |
|
$ |
5 |
|
$ |
2 |
|
$ |
1 |
|
In March 2016, the Company remeasured the liability related to its hourly plan in the U.S. to reflect certain changes in future benefits. The remeasurement resulted in an increase to its pension liability of approximately $60 million and has been reflected in other comprehensive income.
7. Income Taxes
The Company performs a quarterly review of the annual effective tax rate and makes changes if necessary based on new information or events. The estimated annual effective tax rate is forecasted quarterly using actual historical information and forward-looking estimates. The estimated annual effective tax rate may fluctuate due to changes in forecasted annual operating income; changes in the forecasted mix of earnings by country; changes to the valuation
10
allowance for deferred tax assets (such changes would be recorded discretely in the quarter in which they occur); changes to actual or forecasted permanent book to tax differences (non-deductible expenses); impacts from future tax settlements with state, federal or foreign tax authorities (such changes would be recorded discretely in the quarter in which they occur); or impacts from tax law changes. To the extent such changes impact deferred tax assets/liabilities, these changes would generally be recorded discretely in the quarter in which they occur. Additionally, the annual effective tax rate differs from the statutory U.S. Federal tax rate of 35% primarily because of valuation allowances in some jurisdictions and varying non-U.S. tax rates.
The Company is currently under examination in various tax jurisdictions in which it operates, including Argentina, Bolivia, Brazil, China, Canada, Colombia, Czech, Ecuador, France, Germany, Indonesia, and Italy. The years under examination range from 2006 through 2015. The Company has received income tax assessments in excess of established reserves. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if income tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact to the Company’s results of operations, financial position or cash flows.
8. Debt
The following table summarizes the long-term debt of the Company:
|
|
March 31, |
|
December 31, |
|
March 31, |
|
|||
|
|
2017 |
|
2016 |
|
2016 |
|
|||
Secured Credit Agreement: |
|
|
|
|
|
|
|
|
|
|
Revolving Credit Facility: |
|
|
|
|
|
|
|
|
|
|
Revolving Loans |
|
$ |
285 |
|
$ |
— |
|
$ |
288 |
|
Term Loans: |
|
|
|
|
|
|
|
|
|
|
Term Loan A |
|
|
1,370 |
|
|
1,395 |
|
|
1,534 |
|
Term Loan A (€279 million) |
|
|
284 |
|
|
282 |
|
|
309 |
|
Term Loan B |
|
|
|
|
|
|
|
|
558 |
|
Senior Notes: |
|
|
|
|
|
|
|
|
|
|
6.75%, due 2020 (€500 million) |
|
|
530 |
|
|
523 |
|
|
561 |
|
4.875%, due 2021 (€330 million) |
|
|
350 |
|
|
345 |
|
|
370 |
|
5.00%, due 2022 |
|
|
495 |
|
|
495 |
|
|
494 |
|
5.875%, due 2023 |
|
|
683 |
|
|
682 |
|
|
680 |
|
3.125%, due 2024 (€725 million at March 31, 2017 and €500 million at December 31, 2016) |
|
|
763 |
|
|
520 |
|
|
|
|
5.375%, due 2025 |
|
|
297 |
|
|
297 |
|
|
296 |
|
6.375%, due 2025 |
|
|
294 |
|
|
294 |
|
|
294 |
|
Senior Debentures: |
|
|
|
|
|
|
|
|
|
|
7.80%, due 2018 |
|
|
22 |
|
|
250 |
|
|
250 |
|
Capital Leases |
|
|
56 |
|
|
57 |
|
|
58 |
|
Other |
|
|
26 |
|
|
26 |
|
|
32 |
|
Total long-term debt |
|
|
5,455 |
|
|
5,166 |
|
|
5,724 |
|
Less amounts due within one year |
|
|
24 |
|
|
33 |
|
|
62 |
|
Long-term debt |
|
$ |
5,431 |
|
$ |
5,133 |
|
$ |
5,662 |
|
On April 22, 2015, the Company entered into a Senior Secured Credit Facility, which subsequently has been amended several times with the most recent amendment being entered into on February 3, 2016 (the “Amended Agreement”).
At March 31, 2017, the Amended Agreement includes a $300 million revolving credit facility, a $600 million multicurrency revolving credit facility, a $1,575 million term loan A facility ($1,370 million net of debt issuance costs), and a €279 million term loan A facility ($284 million net of debt issuance costs), each of which has a final maturity date of April 22, 2020. At March 31, 2017, the Company had unused credit of $599 million available under the Amended
11
Agreement. The weighted average interest rate on borrowings outstanding under the Amended Agreement at March 31, 2017 was 2.46%.
The Amended Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.
The Amended Agreement also contains one financial covenant, a Total Leverage Ratio that requires the Company not to exceed a ratio calculated by dividing consolidated total debt, less cash and cash equivalents, by consolidated EBITDA, as defined in the Amended Agreement. The Total Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Total Leverage Ratio to exceed the specified maximum of (i) 4.5x for the three fiscal quarters ending March 31, 2017, June 30, 2017 and September 30, 2017, and (ii) 4.0x for the fourth fiscal quarter ending December 31, 2017 and each fiscal quarter thereafter.
Failure to comply with these covenants and restrictions could result in an event of default under the Amended Agreement. In such an event, the Company would be unable to request borrowings under the revolving facility, and all amounts outstanding under the Amended Agreement, together with accrued interest, could then be declared immediately due and payable. If an event of default occurs under the Amended Agreement and the lenders cause all of the outstanding debt obligations under the Amended Agreement to become due and payable, this would result in a default under a number of other outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of March 31, 2017, the Company was in compliance with all covenants and restrictions in the Amended Agreement. In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the Amended Agreement will not be adversely affected by the covenants and restrictions.
The interest rates on borrowings under the Amended Agreement are, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the Amended Agreement, plus an applicable margin. The applicable margin for the term loan A facility and the revolving credit facility is linked to the Company’s Total Leverage Ratio and ranges from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for Base Rate loans. In addition, a facility fee is payable on the revolving credit facility commitments ranging from 0.20% to 0.30% per annum linked to the Total Leverage Ratio.
Borrowings under the Amended Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Borrowings are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign subsidiaries. All borrowings under the Amended Agreement are guaranteed by certain domestic subsidiaries of the Company.
During August 2015, the Company issued senior notes with a face value of $700 million that bear interest at 5.875% and are due August 15, 2023 (the “Senior Notes due 2023”) and senior notes with a face value of $300 million that bear interest at 6.375% and are due August 15, 2025 (together with the Senior Notes due 2023, the “2015 Senior Notes”). The 2015 Senior Notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds from the 2015 Senior Notes, after deducting the debt discount and debt issuance costs, totaled approximately $972 million.
During November 2016, the Company issued senior notes with a face value of €500 million that bear interest at 3.125% and are due November 15, 2024 (the “Senior Notes due 2024”). The notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately $520 million and were used to repay the term loan B facility under the Amended Agreement. In March 2017, the Company expanded its borrowings under the Senior Notes due 2024 by issuing €225 million of additional notes that bear interest at 3.125% and are due November 15, 2024. The notes were issued via a private placement and are guaranteed by certain of the Company‘s domestic subsidiaries. The net proceeds, after
12
deducting debt issuance costs, totaled approximately $237 million and were used to repay a portion of the Company’s revolving credit facility.
In March 2017, the Company purchased in a tender offer approximately $228 million aggregate principal amount of its 7.80% Senior Debentures due in 2018. Approximately $22 million of the Senior Debentures remain outstanding as of March 31, 2017. As part of the tender offer, the Company recorded $17 million of additional interest charges for note repurchase premiums and the related write-off of unamortized finance fees in the first quarter of 2017.
The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.
The Company has a €185 million European accounts receivable securitization program, which extends through March 2019, subject to periodic renewal of backup credit lines.
Information related to the Company’s accounts receivable securitization program is as follows:
|
|
March 31, |
|
December 31, |
|
March 31, |
|
|||
|
|
2017 |
|
2016 |
|
2016 |
|
|||
Balance (included in short-term loans) |
|
$ |
148 |
|
$ |
152 |
|
$ |
157 |
|
Weighted average interest rate |
|
|
0.88 |
% |
|
0.74 |
% |
|
1.03 |
% |
The carrying amounts reported for the accounts receivable securitization program, and certain long-term debt obligations subject to frequently redetermined interest rates, approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy.
Fair values at March 31, 2017 of the Company’s significant fixed rate debt obligations are as follows:
|
|
Principal |
|
Indicated |
|
|
|
|||
|
|
Amount |
|
Market Price |
|
Fair Value |
|
|||
Senior Notes: |
|
|
|
|
|
|
|
|
|
|
6.75%, due 2020 (€500 million) |
|
$ |
534 |
|
$ |
119.56 |
|
$ |
638 |
|
4.875%, due 2021 (€330 million) |
|
|
352 |
|
|
113.94 |
|
|
401 |
|
5.00%, due 2022 |
|
|
500 |
|
|
103.00 |
|
|
515 |
|
5.875%, due 2023 |
|
|
700 |
|
|
105.95 |
|
|
742 |
|
3.125%, due 2024 (€725 million) |
|
|
774 |
|
|
100.09 |
|
|
775 |
|
6.375%, due 2025 |
|